Approaches to improve metabolic stability of a statine-based GRP receptor antagonist

This publication has 29 references indexed in Scilit:

• GRP Receptor Imaging of Prostate Cancer Using [99mTc]Demobesin 4: a First-in-Man Study
  Molecular Imaging and Biology, 2014
• In Vitro and In Vivo Evaluation of a 18F-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging
  PLOS ONE, 2013
• Gastrin Releasing Peptide Receptor-Directed Radioligands Based on a Bombesin Antagonist: Synthesis, ¹¹¹In-Labeling, and Preclinical Profile
  Journal of Medicinal Chemistry, 2013
• Nuclear Imaging Probes: from Bench to Bedside
  Clinical Cancer Research, 2007
• Radiolabeled somatostatin receptor antagonists are preferable to agonists forin vivopeptide receptor targeting of tumors
  Proceedings of the National Academy of Sciences, 2006
• Gastrin-Releasing Peptide Receptors in Normal and Neoplastic Human Uterus: Involvement of Multiple Tissue Compartments
  The Journal of Clinical Endocrinology & Metabolism, 2005
• Potent Bombesin-like Peptides for GRP-Receptor Targeting of Tumors with ^99mTc: A Preclinical Study
  Journal of Medicinal Chemistry, 2004
• Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study
  European Journal of Nuclear Medicine and Molecular Imaging, 2000
• The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers
  Regulatory Peptides, 2000
• Gastrin-Releasing Peptide Receptors in Non-Neoplastic and Neoplastic Human Breast
  The American Journal of Pathology, 1999